Search research articles
Contact Us
Filters
Showing results (71-80 of 80) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 80 results.
Translational Neurodegeneration
|
December 4, 2023
Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer's disease mouse model
Carolyn Tallon, Benjamin J Bell, Medhinee M Malvankar, et al.
Scientific Reports
|
December 12, 2018
DPTIP, a newly identified potent brain penetrant neutral sphingomyelinase 2 inhibitor, regulates astrocyte-peripheral immune communication following brain inflammation
Camilo Rojas, Elena Barnaeva, Ajit G Thomas, et al.
Science Translational Medicine
|
December 17, 2025
An orally bioavailable MrgprX1-positive allosteric modulator alleviates certain neuropathic pain-related behaviors in humanized mice
Ankit Uniyal, Niyada Hin, Chi Zhang, et al.
Journal of Medicinal Chemistry
|
September 10, 2019
Discovery of Benzamidine- and 1-Aminoisoquinoline-Based Human MAS-Related G-Protein-Coupled Receptor X1 (MRGPRX1) Agonists
Eva Prchalová, Niyada Hin, Ajit G Thomas, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
April 29, 2021
Correction to: Glutamine Antagonist JHU083 Normalizes Aberrant Glutamate Production and Cognitive Deficits in the EcoHIV Murine Model of HIV-Associated Neurocognitive Disorders
Michael T Nedelcovych, Boe-Hyun Kim, Xiaolei Zhu, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
June 19, 2019
Glutamine Antagonist JHU083 Normalizes Aberrant Glutamate Production and Cognitive Deficits in the EcoHIV Murine Model of HIV-Associated Neurocognitive Disorders
Michael T Nedelcovych, Boe-Hyun Kim, Xiaolei Zhu, et al.
Cells
|
February 12, 2026
Dendrimer-Conjugated Glutamine Antagonist, D-TTM020, Ameliorates Brain Immune Dysregulation and Improves Neurobehavioral Deficits in the <i>Mecp2-</i>Deficient Mouse Model
Preeti Vyas, Elizabeth Smith Khoury, Nirnath Sah, et al.
Journal of Medicinal Chemistry
|
February 4, 2022
Thieno[2,3-<i>d</i>]pyrimidine-Based Positive Allosteric Modulators of Human Mas-Related G Protein-Coupled Receptor X1 (MRGPRX1)
Ilyas Berhane, Niyada Hin, Ajit G Thomas, et al.
Science Advances
|
November 16, 2022
Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug
Rana Rais, Kathryn M Lemberg, Lukáš Tenora, et al.
The Journal of Clinical Investigation
|
April 28, 2015
Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis
Yan Xiang, Zachary E Stine, Jinsong Xia, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 80) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 80 results.
Translational Neurodegeneration
|
December 4, 2023
Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer's disease mouse model
Carolyn Tallon, Benjamin J Bell, Medhinee M Malvankar, et al.
Scientific Reports
|
December 12, 2018
DPTIP, a newly identified potent brain penetrant neutral sphingomyelinase 2 inhibitor, regulates astrocyte-peripheral immune communication following brain inflammation
Camilo Rojas, Elena Barnaeva, Ajit G Thomas, et al.
Science Translational Medicine
|
December 17, 2025
An orally bioavailable MrgprX1-positive allosteric modulator alleviates certain neuropathic pain-related behaviors in humanized mice
Ankit Uniyal, Niyada Hin, Chi Zhang, et al.
Journal of Medicinal Chemistry
|
September 10, 2019
Discovery of Benzamidine- and 1-Aminoisoquinoline-Based Human MAS-Related G-Protein-Coupled Receptor X1 (MRGPRX1) Agonists
Eva Prchalová, Niyada Hin, Ajit G Thomas, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
April 29, 2021
Correction to: Glutamine Antagonist JHU083 Normalizes Aberrant Glutamate Production and Cognitive Deficits in the EcoHIV Murine Model of HIV-Associated Neurocognitive Disorders
Michael T Nedelcovych, Boe-Hyun Kim, Xiaolei Zhu, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
June 19, 2019
Glutamine Antagonist JHU083 Normalizes Aberrant Glutamate Production and Cognitive Deficits in the EcoHIV Murine Model of HIV-Associated Neurocognitive Disorders
Michael T Nedelcovych, Boe-Hyun Kim, Xiaolei Zhu, et al.
Cells
|
February 12, 2026
Dendrimer-Conjugated Glutamine Antagonist, D-TTM020, Ameliorates Brain Immune Dysregulation and Improves Neurobehavioral Deficits in the <i>Mecp2-</i>Deficient Mouse Model
Preeti Vyas, Elizabeth Smith Khoury, Nirnath Sah, et al.
Journal of Medicinal Chemistry
|
February 4, 2022
Thieno[2,3-<i>d</i>]pyrimidine-Based Positive Allosteric Modulators of Human Mas-Related G Protein-Coupled Receptor X1 (MRGPRX1)
Ilyas Berhane, Niyada Hin, Ajit G Thomas, et al.
Science Advances
|
November 16, 2022
Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug
Rana Rais, Kathryn M Lemberg, Lukáš Tenora, et al.
The Journal of Clinical Investigation
|
April 28, 2015
Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis
Yan Xiang, Zachary E Stine, Jinsong Xia, et al.
Page
of 8